<DOC>
	<DOCNO>NCT00994305</DOCNO>
	<brief_summary>Investigate therapeutic effect antioxidant N-acetylcysteine early outcome decease renal transplant patient .</brief_summary>
	<brief_title>Protective Effect N-acetylcysteine Early Outcomes Deceased Renal Transplant</brief_title>
	<detailed_description>Investigate therapeutic effect 600 mg bid po N-acetylcysteine early outcome decease renal transplant patient regard oxidative stress renal function . Adult primary graft recipient decease renal donor randomly assign treatment ( NAC ) control group prospectively evaluate 90 day . Treatment group receive N-acetylcysteine 600 mg bid po 0 7th postoperative day ( PO ) . Renal function determine serum creatinine , Cockroft-Gault estimate GFR ( eGFR ) 7th , 15th , 30th , 60th 90th PO dialysis free Kaplan-Meier estimate curve . Serum level thiobarbituric acid reactive substance ( TBARS ) , marker lipid peroxidation oxidative stress , determine use thiobarbituric acid assay 0-7th PO . Statistical analysis perform use SPSS 16.0 .</detailed_description>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>primary decease renal transplant recipient adult ( &gt; 18 yo ) unable drink Nacetylcysteine first 7 PO participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>kidney transplantation</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>acetylcysteine</keyword>
	<keyword>graft rejection</keyword>
</DOC>